ARTICLE | Clinical News
Bone morphogenic protein-2: Sofamor Danek will begin testing BMP-2
December 9, 1996 8:00 AM UTC
Sofamor Danek Group Inc., Memphis, Tenn. Product: Bone morphogenic protein-2 (BMP-2) Indication: Adjunct to spinal fusion to treat degenerated lumbar disc disease Status: Sofamor Danek will begin test...